Composition for Improving Membrane Composition and Functioning of Cells
AssigneeN.V. Nutricia
InventorsRobert Johan Joseph HAGEMAN, Mattheus Cornelis DE WILDE, Patrick Joseph Gerardus Hendrikus KAMPHUIS
Life of this patent
Estimating the term…
Loading patent…
AssigneeN.V. Nutricia
InventorsRobert Johan Joseph HAGEMAN, Mattheus Cornelis DE WILDE, Patrick Joseph Gerardus Hendrikus KAMPHUIS
Estimating the term…
It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises: a) a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.
Use of:
A composition for improving cognitive function in elderly subjects, the composition having an energy content of 50-120 kcal, a protein content of 1-10 g, a lipids content of lipids 1-5 g, and a content of digestible carbohydrates of 4-20 g, which composition comprises:
A ready-to-drink liquid for Alzheimer patients that comprises per 100 ml of the following:
A powdered anti-allergic infant formulation, which comprises after fresh reconstitution of 15.4 g powder per 100 ml water:
Dependencies are inferred from the claim text.